Levanix 4mg & 10mg (Lenvatinib)

What is Levanix 4mg & 10mg (Lenvatinib) ?

Lenvanix 4mg (Lenvatinib) is a multiple receptor tyrosine kinase inhibitor (TKI). It is in a class of medication to treat hepatocellular carcinoma (HCC) and advanced renal cell carcinoma (RCC). To treat renal cell carcinoma, doctors use lenvatinib in combination with everolimus.

Health care professionals also suggest lenvanix to treat differentiated thyroid cancer (DTC), which is not treatable with radioactive iodine. In addition, in combination with other medications, they also suggest lenvanix to treat kidney cancer.

This is one of the most successful medicines for treating DTC, HCC, and RCC.

Mechanism of Action of Lenvanix

Lenvanix is a tyrosine kinase inhibitor. It works by blocking the enzymes, which are responsible for the growth of cancer cells. Doing that it can slow or stops the growth of cancer cells, production and division of the cells.

Further, it helps those cells’ promote their death, reducing the risk of side effects. By doing these, it helps to improve overall health.

Specifically, lenvatinib inhibits the following tyrosine kinases:

• Vascular endothelial growth factor receptors
• Fibroblast growth factor receptors
• Platelet-derived growth factor receptor alpha
• c-Kit
• RET proto-oncogene

Tyrosine kinases play a crucial role in tumour growth and progression. Blocking their activity can slow or stop cancer cell growth. Lenvatinib also has anti-angiogenic effects, blocking the formation of new blood vessels essential for tumour growth and metastasis.

Side Effects of Using Levanix 4mg & 10mg (Lenvatinib):

Lenvatinib has a few side effects, including

• diarrhea
• fatigue
• hypertension
• proteinuria
• decreased appetite
• nausea, stomatitis
• and dysphonia.
• shortness of breath
• blood pressure
• irregular heartbeat

If you have any serious side effects, inform your doctor. He will adjust your dosage and may change the prescription. [3]

What is the dosage and administration for Lenvatinib (lenvanix)?

For Thyroid Cancer: Patients with recurrent metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer should take 24 mg of lenvatinib every day.

For advanced renal cell carcinoma, patients with RCC should take 20mg of lenvatinib plus 200 IVs of pembrolizumab daily.

Adults with hepatocellular carcinoma should take 8 mg (weight less than 60 kg) and 12 mg (weight more than 60 kg) daily.

Precautions before taking Levanix4/10mg-Lenvatinib

If your doctor suggests lenvatinib, please share your previous medical history with him or her. As it has some side effects, make sure it does not become deadly for you. Do not take lenvatinib; listen to its benefits. Moreover, a proper diagnosis of cancer is very important before taking lenvatinib.

Tell your doctor if you are currently taking other medications because it may create further complications.

Consult with your doctor if you are already suffering from other cancers, like liver cancer or any other cancer.

Do not take any vitamins, calcium, or other medicines like that without your doctor’s concern.

Tell your doctor if you are breast-feeding or if you have to plan for breast-feeding your unborn baby. The doctor may prohibit you from breastfeeding until one week after the final dose.

Inform your doctor if you have a plan to undergo any surgery or radiation therapy. If you have high blood pressure, also tell him or her.

Follow your regular diet if your doctor does not suggest you change it.

Storage and Disposal of Lenvatinib

Store this medication in a dry and neat place. Keep it at room temperature and out of reach of children.

Do not store this medicine in a wet or moist place; otherwise, it will lose it’s efficiency.

Do not consume lenvatinib with alcohol or any other drinks that have alcoholic chemicals. Always check the expiration date before taking.

You can keep it in the fridge if you dissolve it with water or apple juice for 24 hours.

In case of emergency or overdose:

Contact your doctor if you have any emergencies after taking Lenvanix. Make sure not to inform your doctor if you take an overdose of lenvanix. It is very important to let them know; otherwise, it can be deadly.

You must follow your prescription and diagnosis process at the given time. It will help to monitor your progress.

Lenvatinib and pembrolizumab:

Lenvatinib and pembrolizumab are two cancer drugs. To treat advanced endometrial cancer, doctors suggest using both medications together. Lenvatinib slows down cancer cell growth and promotes their death.

It is a programmed cell death protein 1 (PD-1) inhibitor. That helps T cells recognise and attack cancer cells. The combination is effective. Patients who are receiving lenvatinib and pembrolizumab have a longer overall progression of survival compared to chemotherapy alone.

Lenvatinib (Lenvanix)  FDA approval

The US Food and Drug administration has approved lenvatinib as a first line treatment for unresectable hepatocellulor carcinoma in august 18, 2016. First line treatment means after diagnosis of hepatocellulor carcinoma doctor will suggest patient to take lenvatinib as a first medication.

How do I order Levanix 4mg & 10mg (Lenvatinib)?

It is very simple to order Lenvanix; just scan our QR code or contact us in WhatsApp at +8801304498958. We are also available in , Facebook, WhatsApp, Instagram, linked in and twitter.

See our other products, Fitaro, Axinix-5mg, Palbonix100/125mg, Ibrutix-140mg, Cabozanix-20mg,

Read how PARP inhibitors works in Ovarian cancer

How effective is Levanix 4mg & 10mg (Lenvatinib) ?

Lenvatinib is very effective in treating DTC, HCC, and RCC. However, it can cause side effects like diarrhoea, fatigue, hypertension, proteinuria, decreased appetite, nausea, stomatitis, and dysphonia. Patients should inform their doctors if they experience any serious side effects. They should also consult their doctor to adjust their dosage.

What is the brand name of lenvatinib?

Lenvatinib is a group of tyrosine kinase inhibitors. Lenvima is the brand name of Lenvatinib.

Is lenvatinib a chemotherapy drug?

Lenvatinib is not a chemotherapy drug. It is a targeted therapy drug that affects specific molecules that are responsible for cancer cell growth. Lenvatinib blocks the proteins in those cells that help slow the growth of cancer cells.